Risk factors for in-hospital mortality in laboratory-confirmed COVID-19 patients in the Netherlands: A competing risk survival analysis

Author:

Nijman Gerine,Wientjes Maike,Ramjith JordacheORCID,Janssen NicoORCID,Hoogerwerf Jacobien,Abbink Evertine,Blaauw Marc,Dofferhoff Ton,van Apeldoorn Marjan,Veerman Karin,de Mast Quirijn,ten Oever Jaap,Hoefsloot Wouter,Reijers Monique H.,van Crevel Reinout,van de Maat Josephine S.ORCID

Abstract

Background To date, survival data on risk factors for COVID-19 mortality in western Europe is limited, and none of the published survival studies have used a competing risk approach. This study aims to identify risk factors for in-hospital mortality in COVID-19 patients in the Netherlands, considering recovery as a competing risk. Methods In this observational multicenter cohort study we included adults with PCR-confirmed SARS-CoV-2 infection that were admitted to one of five hospitals in the Netherlands (March to May 2020). We performed a competing risk survival analysis, presenting cause-specific hazard ratios (HRCS) for the effect of preselected factors on the absolute risk of death and recovery. Results 1,006 patients were included (63.9% male; median age 69 years, IQR: 58–77). Patients were hospitalized for a median duration of 6 days (IQR: 3–13); 243 (24.6%) of them died, 689 (69.9%) recovered, and 74 (7.4%) were censored. Patients with higher age (HRCS 1.10, 95% CI 1.08–1.12), immunocompromised state (HRCS 1.46, 95% CI 1.08–1.98), who used anticoagulants or antiplatelet medication (HRCS 1.38, 95% CI 1.01–1.88), with higher modified early warning score (MEWS) (HRCS 1.09, 95% CI 1.01–1.18), and higher blood LDH at time of admission (HRCS 6.68, 95% CI 1.95–22.8) had increased risk of death, whereas fever (HRCS 0.70, 95% CI 0.52–0.95) decreased risk of death. We found no increased mortality risk in male patients, high BMI or diabetes. Conclusion Our competing risk survival analysis confirms specific risk factors for COVID-19 mortality in a the Netherlands, which can be used for prediction research, more intense in-hospital monitoring or prioritizing particular patients for new treatments or vaccination.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference37 articles.

1. Dutch National Institute for Public Health and the Environment (RIVM). Patient with novel coronavirus COVID-19 in the Netherlands 2020 [updated 27-02-2020. Available from: https://www.rivm.nl/en/news/patient-with-novel-coronavirus-covid-19-in-netherlands.

2. Dutch National Institute for Public Health and the Environment (RIVM). Current information about the novel coronavirus (COVID-19) 2020 [updated 06-04-2020. Available from: https://www.rivm.nl/en/current-information-about-novel-coronavirus-covid-19.

3. Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal;L Wynants;BMJ,2020

4. Ignoring competing events in the analysis of survival data may lead to biased results: a nonmathematical illustration of competing risk analysis;NA Schuster;Journal of clinical epidemiology,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3